Finally, we verified the transcription and protein expression levels of these two genes in clinical tumor tissues and conducted in vitro experiments to determine the role of PYCR1 and MELK in immune infiltration and OS in ccRCC, thereby determining the mechanism by which these genes affect tumor progression. This evidence concerns the gene PYCR1 and nonpapillary renal cell carcinoma.